Tampa General Hospital Cancer Institute Recognized on Becker’s List of ‘100 Hospital and Health Systems with Great Oncology Programs’ for 2023 | Tampa General Hospital

Tampa General Hospital Cancer Institute Recognized on Becker’s List of ‘100 Hospital and Health Systems with Great Oncology Programs’ for 2023

Published: Oct 19, 2023

Tampa, FL (Oct. 19, 2023) – The Tampa General Hospital (TGH) Cancer Institute has been named to Becker’s Hospital Review’s list of “100 Hospitals and Health Systems with Great Oncology Programs” for 2023. This award recognizes the outstanding contributions of the TGH Cancer Institute to cancer care and research, placing it among the nation’s foremost institutions that have earned national recognition for their exceptional work in the field.


“We are immensely proud to be the only health system in Tampa Bay recognized by Becker’s for delivering excellence in cancer care,” said John Couris, president and CEO of Tampa General. “Over the past year, our world-class oncology team has continued to drive innovation in the treatment and research of even the most complex cancers. This accolade is a testament to those efforts, as well as the ongoing work of the entire team to increase access to cancer treatment and prevention in West Central Florida and the continued practice of cutting-edge and compassionate care.”

Part of the region’s leading academic health system, the TGH Cancer Institute is a world-class cancer center providing comprehensive, innovative care. Through groundbreaking therapies and advanced diagnostic imaging tools, the Institute efficiently diagnoses, comprehensively evaluates and treats all forms of cancer, including the rarest cancers.

“Our team at the TGH Cancer Institute understands that our relentless pursuit of breakthrough research and innovation represents a beacon of hope to our patients and their loved ones,” said Dr. Eduardo M. Sotomayor, vice president and executive director of the TGH Cancer Institute. “The real, human impact of our work is what inspires and drives our team, and it is that much more rewarding to be recognized by Becker’s for the exceptional quality of care we deliver as a result.”

Tampa General has hand-selected the country’s top cancer specialists, surgeons and researchers to join its multidisciplinary team comprised of experts in radiation oncology, medical oncology/hematology, surgical oncology, bone marrow transplant and cellular therapies, gynecologic oncology, radiology and pathology. Their work is supported by the Institute’s ancillary support services, including social work, nutrition, rehabilitation, psychology, genetic counseling, patient navigation and palliative care.

The TGH Cancer Institute has expanded its footprint and impact considerably within the past year, recently opening a 26-bay infusion center. The infusion center is the latest satellite addition in the Brandon, Florida facility which first opened in Fall 2022 and increased access to best-in-class cancer care for the Tampa Bay community.

As a leader in cancer research and clinical innovation, the Institute’s researchers are actively developing new and more effective treatments for cancer and offering patients access to a wide range of clinical trials as well as opportunities to try new and promising treatments before they are widely available.

“Our multidisciplinary approach to cancer care ensures that our patients have access to unmatched expertise and the best possible treatment options and outcomes,” said Dr. Abraham Schwarzberg, executive vice president, chief of oncology and president of the Tampa General Provider Network (TGPN). “We work closely with our patients to develop personalized treatment plans that meet their individual needs and goals and leverage our academic affiliation with the USF Health Morsani College of Medicine to continue advancing breakthrough research and treatment.”

The TGH Cancer Institute is accredited by the Commission on Cancer (CoC), a quality program established by the American College of Surgeons (ACS). This accreditation recognizes the Institute’s adherence to 34 quality care standards and its commitment to improving patient outcomes and quality of life.


Becker’s Hospital Review, a trusted authority in health care news and information, compiles this annual list to showcase organizations that have demonstrated excellence in cancer care. These distinguished institutions are known for their leadership in pioneering clinical trials, groundbreaking research discoveries and their unwavering dedication to expanding access to care while improving patient outcomes.


Inclusion on this list is the latest among several recent achievements for the TGH Cancer Institute, including:


Tampa General and the rest of this year’s “100 Hospitals and Health Systems with Great Oncology Programs” honorees are profiled online here.